Jim Tullis is the founder and chief executive officer of Tullis Health Investors. Under his direction, the firm has invested in a portfolio of companies representing innovative concepts in pharmaceuticals, biotechnology, managed care, health insurance, health care information technology, logistics and distribution, and medical devices.
Prior to establishing Tullis Health Investors in 1986, Jim worked as an analyst at Morgan Stanley where he managed health care investment research, focusing on pharmaceuticals and medical devices. During his tenure on Wall Street, he received many accolades, including recognition on the Institutional Investor All-Star list of Wall Street's top securities analysts. He was twice named #1 Drug Analyst, was featured on the Wall Street Week television program, and authored Wall Street's first research report on biotechnology.
He currently serves on the Boards of several public and private companies. Jim is a graduate of Stanford University and earned an MBA from Harvard Business School.
